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Aristolochic acid contamination in herbal remedies leads to
interstitial fibrosis, tubular atrophy, and renal failure in
humans. To study the cellular mechanisms contributing to
the pathophysiology of this renal disease, we studied Wistar
rats treated with aristolochic acid and measured tubular and
interstitial cell proliferation, epithelial/mesenchymal cell
marker expression, tubular membrane integrity,
myofibroblast accumulation, oxidative stress, mitochondrial
damage, tubular apoptosis, and fibrosis. Oxidative stress,
a loss of cadherin concomitant with vimentin expression,
basement membrane denudation with active caspase-3
expression, and mitochondrial injury within tubular cells
were evident within 5 days of administration of the toxin.
During the chronic phase, interstitial mesenchymal cells
accumulated in areas of collagen deposits. Impaired
regeneration and apoptosis of proximal tubular cells resulted
in tubule atrophy with a near absence of dedifferentiated cell
transmembrane migration. We suggest that resident
fibroblast activation plays a critical role in the process of
renal fibrosis during aristolochic acid toxicity.
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The respective role of epithelial to mesenchymal transition
(EMT) of tubular epithelial cells and inflammatory cells in
the progression of tubulointerstitial (TI) lesions—from
tubular necrosis to interstitial fibrosis—remains a matter of
debate.1,2 We decided thus to investigate some aspects of
those processes in the rat model of aristolochic acid (AA)
nephrotoxicity. Aristolochic acid nephropathy (AAN) is a TI
nephritis of toxic origin rapidly progressing to fibrosis
reported in individuals after the intake of AA contained in
some herbal remedies.3 Renal function deteriorated rapidly,
leading to end-stage renal failure in several months.3 The
progression of AAN was characterized by variable intensity of
lymphocyte infiltration, prominent tubular atrophy, and
TI fibrosis with microscopically intact glomeruli.4 Prior
exposure to AA resulted in specific AA–DNA adducts
formation in kidney tissue samples, detectable even years
after AA intoxication.5,6
Human AAN was reproduced in rabbit and rodents.7,8 In
Wistar rats, AA intoxication resulted in tubular atrophy and
interstitial fibrosis leading to renal failure after 35 days.8 An
early tubular proteinuria was related to a defect of megalin-
mediated endocytosis of albumin by the proximal tubular
epithelial cells (PTECs), confirming previous in vitro
observations.9,10 After approximately 20 days of AA injection,
a transient decrease in proximal tubule enzymuria was
observed,9 reflecting an attempt of PTEC regeneration.
Physiologically, renal repair after acute injury is conditioned
by regeneration and proliferation of surviving epithelial
cells.11,12 As in vivo and in vitro studies confirmed the
formation of specific AA–DNA adducts in renal epithelial
cells,5,6,9,10 these adducts could interfere with PTEC prolifera-
tion capacity, negatively influencing regeneration. However, the
implication of apoptosis has been demonstrated in models of
chronic kidney disease and should also be considered as a
possible mechanism of tubular epithelial cell deletion.13
We thus hypothesized that AA sustained intoxication
results in altered PTEC regeneration and apoptosis leading to
subsequent irreversible proximal tubular atrophy. Moreover,
as atrophic tubules were surrounded by interstitial fibrosis,
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we investigated the presence of EMT as a potential
mechanism of renal scarring. The defining steps of EMT
were adapted from Yang and Liu14 as follows: (1) loss of
epithelial cell adhesion, (2) vimentin and alpha smooth
muscle actin (a-SMA) expression, (3) tubular basement
membrane disruption, and (4) migration of dedifferentiated
cells across this disrupted membrane. Finally, we addressed
the association between changes in oxidative stress para-
meters and PTEC apoptosis with the development of
morphological changes (fibrosis and tubular atrophy).
This study demonstrated that AA tubulotoxicity resulted
in defective activation of antioxidative enzymes and mito-
chondrial damage. The progressive tubular atrophy was
related to impaired regeneration and apoptosis of PTEC.
Transmembrane migration of PTEC displaying signs of EMT
was rarely observed. The accumulation of vimentin and of
a-SMA-positive cells in the interstitial areas expressing
transforming growth factor-b (TGF-b) suggested an increase
in resident peritubular fibroblasts and their activation into
myofibroblasts. Therefore, the activated resident fibroblasts
could be considered as the main source of collagen
deposition during experimental AAN.
RESULTS
TI injury, renal structural and functional markers
TI injury. In the process of experimental AAN, we have
arbitrarily distinguished two phases: an acute phase from day
1 to day 5 and a chronic phase from day 7 to day 35.
Glomeruli were intact in both rat groups. In AA rats,
during the acute phase, signs of oncosis (decreased cytoplasm
eosinophilia reflecting PTEC swelling) and patchy PTEC
necrosis were limited to the outer stripe of outer medulla
(OSOM) (segment S3) (Figure 1a–c). During the chronic
phase, in these areas, tubules became progressively atrophic
and exhibited typical basement membrane thickening (Figure
1d–f). As compared to controls, the total tissue kidney surface
from AA rats at day 35 was significantly reduced ((median
value (min–max) in mm2 per field): 0.034 (0.031–0.037) vs
0.041 (0.037–0.043), Po0.05).
The score of TI injury obtained in AA rats revealed a peak
of tubular necrosis at days 4 and 5 (Figure 1g), followed by
progressive tubular atrophy and interstitial fibrosis (Figure 1h
and i, respectively). A marked lymphocytic infiltration was
also present (Figure 1j).
Renal structural and functional markers. In AA rats, as
compared to controls, a transient increase in PTEC brush-
border DPPIV (dipeptidyl peptidase IV) enzymuria (median
value (min–max) in mmol AMC (7-amido-4-methyl-coumar-
in) product per g creatinine (Cr)) was measured at day 4 (687
(607–765) vs 563 (415–744), Po0.05) followed by a
significant decrease as early as day 7, which persisted until
day 35 (day 7: 185 (147–313) vs 328 (282–410), Po0.01; day
10: 81 (48–118) vs 133 (96–171), Po0.05; day 14: 182
(147–275) vs 387 (276–497), Po0.01; day 18: 216 (173–271)
vs 356 (268–512), Po0.01; day 35: 280 (157–369) vs 527
(374–777), Po0.01).
A significant increase in plasma Cr (median value
(min–max) in mg per 100 ml) was observed from day 3
(0.336 (0.265–0.05) vs 0.222 (0.186–0.26), Po0.01) to day 35
(0.345 (0.25–0.5) vs 0.245 (0.2–0.3), Po0.05).
Interstitial inflammation and urinary excretion of monocyte
chemoattractant protein-1
Contrasting with controls, the renal interstitium from AA
rats was abundantly infiltrated with monocytes/macrophages
and CD8þ lymphocytes from day 3 to day 35. These
inflammatory cells accumulated around damaged PTECs
from the OSOM (Figure 2a–c and d–f), where typical signs of
CD8þ tubulitis, reflecting T-cell cytotoxicity, were evident
(Figure 2g and h).
No statistically significant difference in the urinary
excretion of monocyte chemoattractant protein-1 (MCP-1)
was observed between AA rats and controls during the
acute phase. On the contrary, urinary levels of MCP-1
were significantly increased from day 7 to day 35 in AA rats
(Figure 2i).
Proliferation of tubular cells and DNA damage repair
In AA rats, Ki-67þ cells were observed from day 2 to day 35
(Figure 3a–c). During the acute phase, most of these cells
were identified as PTECs from the S3 segment (neutral
endopeptidase (NEP)/Ki-67 coexpression) (Figure 3d and e).
The onset of tubular proliferation occurring at day 2 was
concomitant with acute tubular necrosis (Figure 3f). During
the chronic phase, the scores of Ki-67þ PTEC and of
tubular atrophy correlated negatively (n¼ 60, r¼0.758,
Po0.0001). The amount of Ki-67þ interstitial cells reflected
a sustained proliferation of infiltrating and/or resident cells
from day 3 to day 35 (Figure 3g).
As of day 1, typical proliferating cell nuclear antigen
positive (PCNAþ ) tubular and interstitial cell clusters were
seen in the corticomedullary junction (Figure 4a and b). At
day 35, PCNA labeling in atrophic tubules contrasted with
strong PCNA expression in interstitial cells (Figure 4c). In the
papilla, proliferating tubular cells were present only during
the acute phase (Figure 4d–f) and were confined to the
medullary ascending thick limb (PCNAþ /cytokeratin 18)
and to the collecting ducts (PCNAþ /cytokeratin 18þ ) (Figure
4g). As compared to controls, the amount of PCNAþ PTECs
was higher in AA rats at all time points (Figure 4h). No
correlation was found between the amount of Ki-67þ and
PCNAþ PTECs (n¼ 60, r¼ 0.227, P¼ 0.084).
PTEC dedifferentiation, tubular basement membrane denu-
dation, and interstitial fibrosis
The percentage of NEPþ PTECs significantly decreased
throughout the chronic phase (Figure 5a). As soon as day 3,
mature PTECs expressed de novo vimentin (mesenchymal cell
marker). These dedifferentiated cells progressively accumu-
lated within damaged nephrons, trapped by interstitial
inflammation (Figure 5b–d). At day 35, atrophic tubules
were colonized exclusively by vimentinþ /NEP cells
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(Figure 5e). Vimentin/Ki-67 coexpression confirmed their
ability to proliferate (Figure 5f).
As early as day 3, NEPþ PTECs lost N-cadherin expres-
sion (as well as E-cadherin; data not shown). The disappear-
ance of epithelial cell–cell adherent junctions was actually
limited to the S3 segment of proximal tubules (Figure 6a–c).
During the acute phase, marked early focal tubular basement
membrane denudations were confirmed by ultrastructural
analysis (electronic microscopy) (Figure 6d–h). Detached
PTECs were found in the tubular lumen. The evidence of
detached cell migration into the interstitium was almost absent.
Intense TGF-b expression by PTECs and adjacent inter-
stitial cells was detected early (day 3) and persisted until
day 35 (Figure 6i–k). From day 7 until day 35, S100A4þ
interstitial mononuclear cells accumulated around injured
PTECs from the S3 segment, which later became areas of
interstitial scarring (data not shown). Acquisition of the
myofibroblast phenotype (a-SMA expression) by tubular and
interstitial cell clusters was seen during the chronic phase
(Figure 7a–c). Sirius red staining revealed the tubular basement
membrane anomalies at days 10 and 35 (Figure 7d–f). At day
35, foci of TI fibrosis identified by the apposition of collagen
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Figure 1 | Representative photomicrographs of kidney sections stained by hematoxylin/eosin and Goldner’s trichrome. Time course
of semiquantitative scores of TI injury. (a and d, day 35) Control rats exhibited intact renal parenchyma. (b, day 1) AA-induced PTEC
oncosis demonstrated by organelle swelling (arrow) and (c, day 4) marked decrease in eosinophilia of PTEC from the outer medulla, including
medullary rays. (e and f, day 35) Tubular degenerative changes, including PTEC atrophy (star) with thickening of the basement membrane
(arrow). Typical areas of interstitial fibrosis extending along the medullary rays up to the subcapsular area observed in AA rats. Original
magnifications: (a, b, and e)  400; (c, d, and f)  40. (g–j) As most data from controls (white boxes) at the majority of time points are
close to zero, they are represented by horizontal lines. (g) Transient increase in the score of tubular necrosis from day 2 to day 5 in AA rats
(gray boxes) was followed 2 weeks later by a progressive increase in the scores of (h) tubular atrophy and (i) interstitial fibrosis. (j) A
significant increase in the lymphocytic infiltrate score persisted throughout the chronic phase. Data are median values together with the
interquartile ranges and the min–max values; *Po0.05, **Po0.01 vs day 1.
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types I and III were typically located along the external part of
the medullary rays (Figure 7g–l).
Oxidative stress, mitochondrial injury, and apoptosis
In the first 2 weeks, following a transient increase in the
urinary excretion rate of nitric oxide metabolites (NOx)
(median (min–max) mmol per mmol Cr), their excretion was
decreased in AA rats as compared to controls (at day 1: 102.6
(83–109) vs 84.0 (42.1–90.4), Po0.05; at day 14: 126
(107–155) vs 183 (148–218), Po0.005). Renal cortex Mn-
superoxide dismutase (SOD) activity did not significantly
change throughout the protocol (Figure 8a). A sustained
increase in glutathione peroxidase activity preceded a delayed
decrease in Cu/Zn-SOD and catalase activities (Figure 8b–d).
At day 35, the cortical concentration of TBARSs (thiobarbi-
turic acid reactive substances) (median (min–max) in pmol
per mg protein) was 80.4 (78.5–84.0) in AA rats and 73.4
(66.2–84.6) in controls (P¼ 0.054).
Intoxication by AA induced changes in the immunostaining
patterns of inducible nitric oxide synthase (iNOS) and
cytochrome c in PTECs from the external parts of the
medullary rays. After a transient enhancement of cytoplasmic
iNOS staining (day 4), the expression dramatically decreased
(Figure 9a–c). A strong, diffuse cytoplasmic cytochrome c
staining reflecting their release from the internal mitochondrial
membrane into the cytoplasm was detected in PTECs as soon
as day 4 (Figure 9d and e). These modifications in cytochrome
c expression persisted until day 35 (Figure 9f). From day 3 to
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Figure 2 | Kidney NEP/ED1 (first row) and NEP/CD8 (second row) immunoperoxidase double stainings and MCP-1 urinary excretion
rate during AAN. (a and d, day 10) Absence of ED1þ and CD8þ cell clusters in control rats. In AA rats, (b and e, day 10) ED1þ and
(c and f, day 35) CD8þ cell clusters (colored in purple) were predominantly observed around injured tubules containing NEP-stained
PTEC (colored in orange). After 10 days of injections, (g) absence of infiltrating CD8þ cells in controls and (h) intratubular cytotoxic CD8þ cells
(tubulitis; arrow) in AA rats. Sections were counterstained with Mayer’s hematoxylin. Original magnifications: (a–f)  40; (g and h)  400.
(i) As compared to controls (white boxes), significant and sustained increase in MCP-1 urinary excretion rate measured from day 7 to day
35 in AA rats (gray boxes). Data are median values together with the interquartile ranges and the min–max values; *Po0.05, **Po0.01,
***Po0.005 vs controls.
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day 35, PTECs (mainly from the S3 segment) and some distal
tubular cells expressed active caspase-3 (Figure 9g–i).
DISCUSSION
The presently detailed time course of experimental AAN
distinguished two interconnected phases: acute events
occurring during the first phase (transient tubular necrosis)
were complicated by the installation of chronic lesions
seen during the second phase (tubular atrophy and TI
fibrosis). The progressive peritubular accumulation of
monocytes/macrophages and CD8þ T cells was the main
process linking both phases. Indeed, the early transient
AA-induced acute tubular necrosis might be considered as a
crucial event triggering the chemoattraction of leukocytes.15
In our study, the interstitial infiltration by inflammatory cells
preceded increased urinary MCP-1 excretion. The persistence
of interstitial inflammation during the chronic phase may be
related to sustained urinary levels of this chemokine.
According to the clinical and experimental data, TI infiltra-
tion by monocytes/macrophages and T lymphocytes is
known to be associated with fibrogenesis.16,17 Inflammatory
cells and injured PTEC-derived cytokines and chemokines
(mainly MCP-1) by activation of neighboring fibroblasts
contributes to excessive synthesis of the extracellular matrix
and are important mediators of renal fibrosis.16–18
The S3 segment of proximal tubules, which is highly
susceptible to hypoxia,19 was the preferential target of AA. As
intracellular activation/detoxification pathways are likely
triggered by AA intoxication, the transient acute PTEC
necrosis could reflect an imbalance between enhanced oxygen
demand and delivery.20 In addition to Ki-67, PCNA staining
provided additional information regarding DNA damage.
This polymerase cofactor is involved in DNA repair and
stability of the DNA microsatellite region.21 The disappear-
ance of PCNA expression from PTEC might be considered as
a defect of DNA repair in response to specific AA–DNA
adducts formation ultimately leading to defective cell
proliferation and the development of tubular atrophy. A
similar interpretation was previously provided by experi-
mental data obtained from the cisplatin model.22 Moreover,
cell cycle arrest of PTEC in vitro after AA exposure was
recently reported.23
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Figure 3 | Kidney Ki-67 and NEP/Ki-67 immunoperoxidase stainings. Time course of semiquantitative evaluation of Ki-67 expression
by PTEC and interstitial cells. (a) Rare nuclear Ki-67 staining of PTEC in control kidneys (arrow). (b, day 3) Enhanced Ki-67 expression by
PTEC in an AA rat (arrow). (c, day 35) Decreased Ki-67 expression by PTEC (arrow) contrasting with a dramatically increased Ki-67 expression
by interstitial cells (star). (d) Rare NEP/Ki-67 coexpression in a control kidney (arrow). (e, day 4) Numerous NEP/Ki-67 double-stained PTECs
in a representative AA rat (arrows). Sections were counterstained with (a–c) Mayer’s hematoxylin or (d and e) eosin. Original magnification:
 400. (f and g) Sustained increase in Ki-67 labeling observed from day 2 to day 35 in tubular and interstitial compartments in AA rats
(gray boxes), as compared to controls (white boxes). Data are median values together with the interquartile ranges and the min–max
values; *Po0.05, **Po0.01, ***Po0.005 vs controls.
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Acute AA tubulotoxicity resulted in early PTEC dediffer-
entiation reflected by the disappearance of the epithelial
phenotype and acquisition of mesenchymal cell markers by
some PTECs still expressing NEP. The regeneration of PTEC
was confirmed by the proliferation of dedifferentiated cells
(vimentin/Ki-67 coexpression), which should differentiate into
mature epithelial cells under normal conditions.24 In this
model, regenerating cells might originate from injury-resistant
resident progenitor-like tubular cells derived from the S3
segment, since PTEC proliferation was principally observed in
the OSOM. Nevertheless, another possible source of progeni-
tor cells could be proliferating papillary tubular cells, which
exhibited strong PCNA staining at day 4. The decline of PTEC
proliferation together with defective differentiation resulted in
the development of tubular atrophy. In this model, induction
of active caspase-3 in the PTEC from the S3 segment
demonstrated the contribution of PTEC apoptosis in tubular
atrophy. Till now, only two in vitro studies observed such
programmed cell death induced by AA exposure.25,26
Our data also demonstrated that AA intoxication was
associated with defective antioxidative enzyme activation and
mitochondrial damage. Transient iNOS overexpression by
PTEC could explain elevated urinary excretion of NOx.27
During the chronic phase, despite an enhanced glutathione
peroxidase activity, the decline of antioxidant catalase and Cu/
Zn-SOD activities confirmed a decreased capacity to neutralize
oxidative bursts. Peroxinitrite production and lipid peroxida-
tion (elevated levels of TBARS) contributed to the chronic
interstitial inflammation.28 Decreased PTEC eosinophilia and
diffuse cytoplasmic cytochrome c staining were compatible
with mitochondrial damage as previously proposed.29 Chemi-
cal anoxia (mitochondrial energy store depletion)30 could
cause PTEC structural injury31 and dysfunction.9,10,32,33
The pathological significance of EMT in renal fibrosis is
still controversial.1,2,34–36 One point of contention is the
contribution of EMT to fibroblast formation given the fact
that most forms of chronic renal disease are characterized by
thickening rather than disruption of the tubular membrane.
Given our data, the possible involvement of EMT could be
restricted to the basement membrane thickening process
rather than an effective source of interstitial fibroblasts. Early
migration of dedifferentiated epithelial cells could not be
excluded but was unlikely. It was difficult to conclude that
interstitial S100A4þ cells originated from EMT. The lack of
S100A4 specificity for fibroblasts was already described.37 On
the contrary, the peritubular increase in vimentin-positive
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Figure 4 | PCNA immunoperoxidase staining (renal cortex and papilla) from representative control and AA rats. Time course of
quantified PCNA expression in PTEC. Renal cortex: (a, day 1) sporadically PCNA-stained PTEC in controls (arrow), (b) PCNA staining in PTECs
(arrow) and interstitial cells (arrowhead) at day 1 and (c) predominant PCNA expression by interstitial cells (arrowhead) at day 35 in AA rats.
Renal papilla: in control, (d, day 4) absence of PCNA staining. In AA rats, (e, day 4) enhanced PCNA expression by papillary tubular cells (arrow)
in conjunction with the disappearance of PCNA-stained papillary cells (f, day 35). (g, day 4) PCNA (brown)/cytokeratin 18 (red) double
staining: PCNA expression by medullary thick ascending limb (cytokeratin 18 negative; star) and by collecting ducts (cytokeratin 18 positive;
arrow). Sections were counterstained with Mayer’s hematoxylin. Original magnifications: (a–c and g)  400; (d–f)  200. (h) Significant
and persistent increase in PCNA expression by PTECs during both phases of AAN (gray boxes), as compared to controls (white boxes).
Data are median values together with the interquartile ranges and the min–max values; *Po0.05, **Po0.01, ***Po0.005 vs controls.
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cells might suggest an activation of resident fibroblasts. As
a-SMAþ cells accumulated around atrophic tubules in areas
of enhanced TGF-b and collagen type I and III expression,
the involvement of TGF-b in the local activation of quiescent
fibroblasts into myofibroblasts should be considered.38–41
To conclude, AA tubulotoxicity resulted in defective activation
of antioxidative enzymes and mainly mitochondrial damage. Loss
of epithelial markers was concomitant to de novo expression of
mesenchymal cell markers and disruption of the tubular base-
ment membrane. Despite an early induction of proliferation and
dedifferentiation, PTEC did not regain a mature epithelial
phenotype. The progressive tubular atrophy was related to a
defective regeneration of PTEC and induction of apoptosis
secondary to caspase-3 activation. In the absence of transmem-
brane migration of PTEC displaying the typical signs of EMT, the
interstitial accumulation of vimentin-stained cells in areas of
TGF-b expression suggested an increase in activated resident
fibroblasts, which are responsible for collagen deposition, indi-
cating their crucial role in the development of interstitial fibrosis.
MATERIALS AND METHODS
Experimental protocols
Experimental procedures performed in 4-week-old male Wistar rats
(Elevage Janvier, Le Genest Saint-Isle, France)42 approved by the
local Ethic Committee for Animal Care were conducted according to
the National Guidelines for the Care and Use of Laboratory Animals.
In our model of experimental AAN,8 contrary to previous studies
in the cyclosporine model, we showed that TI lesions were inde-
pendent of salt intake modulation.42 Therefore, male Wistar rats
receiving a normal sodium diet were used for this study.
We performed two successive protocols as follows: the first one
(n¼ 60 rats) investigated the period from day 1 to day 5 of AA
injections (hereafter referred to as acute phase) and the second one
(n¼ 60 rats) investigated the period from day 7 to day 35 (hereafter
referred to as chronic phase). Six rats from the AA group and six
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Figure 5 | Time course of NEP immunoperoxidase staining during the chronic phase of AAN; NEP/vimentin and vimentin/Ki-67
double staining in representative control and AA rats. (a) Progressive decrease in the percentage of NEPþ PTECs in AA rats (gray boxes),
as compared to controls (white boxes). Data are median values together with the interquartile ranges and the min–max values; *Po0.05,
**Po0.01, ***Po0.005 vs controls. (b, day 3) Constitutive NEP expression on the brush border of PTECs (S3 segment) (arrow) and
vimentin expression by glomerular endothelial cells (star) in a control rat. (c) Cytoplasmic staining of vimentin (arrow) in differentiated
PTEC (star) after 3 days of AA injections. Progressive accumulation of vimentin-positive PTECs (arrow) exhibiting loss of NEP staining (star)
from (d) day 7 to (e) day 35. (f, day 5) Coexpression of Ki-67 and vimentin by PTECs (arrows) in an AA rat. Sections were counterstained
(b–e) with Mayer’s hematoxylin and (f) with eosin. Original magnification:  400.
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control rats were killed at the following time points: days 1, 2, 3, 4, 5,
7, 10, 14, 18, and 35 to obtain the kinetics of investigated events.
Weight-matched animals were randomized into two groups:
the AA group received AA (10 mg per kg of body weight) and
the control group received a solvent of AA (polyethylene glycol 400;
Fluka Chemie, Buchs, Switzerland) in daily subcutaneous injections.
After intraperitoneal anesthesia with ketamine HCl (Merial,
Brussels, Belgium) and 2% xylazine (Bayer, Brussels, Belgium), a
blood specimen was obtained by cardiac puncture. Kidneys were
rapidly harvested and processed. One half of the kidney was fixed in
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Figure 6 | Representative photomicrographs and time course of the semiquantitative score of N-cadherin and Jones membrane
staining. Ultrastructural aspect of the tubular basement membrane of the proximal tubules from the S3 segment. Tissue TGF-b expression
in both rat groups. (a) In control rats, typical basolateral N-cadherin location (arrows) and NEPþ PTEC (S3 segment) (arrowhead).
(b) Early disappearance of N-cadherin (arrows) at the basolateral membrane of mature PTECs as assessed by the presence of intact
nuclei and NEP expression (arrowheads) in rats after 3 days of AA injection. (c) Significant and persistent decrease in basal N-cadherin
expression by PTECs from S3 segment in AA rats (gray boxes) as compared to controls (horizontal bars). (d) Intact tubular and glomerular
membranes in a control rat. (e, day 2) In an AA rat, detachment of PTECs (arrow) from the basement membrane and marked focal membrane
denudation (arrow) limited to the S3 segment. (f) Enhanced score of tubular basement membrane denudation in AA rats (gray boxes) as
compared to controls (horizontal bars). Data are median values together with the interquartile ranges and the min–max values; *Po0.05,
**Po0.01, ***Po0.005 vs day 1. (g) Intact morphology of PTEC and the tubular basement membrane in a control rat. (h, day 2) Tubular
basement membrane rupture (arrow) typically seen in AA rat. (i) Constitutive TGF-b expression in a control rat. (j, day 3 and k, day 35)
Enhanced and persistent TGF-b staining in PTECs (arrows) and interstitial accumulation (stars) in AA rats. (a, b, and i–k) Sections were
counterstained with Mayer’s hematoxylin. Original magnifications: (a, b, and i–k)  400; (d and e)  1000. (g and h) Sections were
counterstained with uranyl acetate and lead citrate. Original magnification:  1100; kindly provided by C Lebeau, PhD (Laboratoire de
Recherche sur le Me´tabolisme des Peptides, Faculty of Medicine, Universite´ Libre de Bruxelles, Brussels, Belgium).
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a buffered solution of 4% formaldehyde (pH 7.4) and paraffin-
embedded (formalin-fixed paraffin-embedded) for morphological
and immunohistochemical evaluations. The remaining half and
samples of contralateral kidney cortex were immediately frozen in
liquid nitrogen (80 1C) for biochemical evaluation. Urine speci-
mens obtained 24 h before killing the animals were stored at 20 1C
for further analysis. Variables studied were summarized in Table 1.
Renal histopathology
The TI injury semiquantification was evaluated on hematoxylin/eosin-
and Goldner’s trichrome-stained formalin-fixed paraffin-embedded
sections.8 Complete kidney sections were analyzed with a light
microscope (Carl Zeiss, Oberkochen, Germany) using a  20
magnification lens by two investigators (AAP and FDD) blind to the
group origin of the rats (AA vs control). The scoring systems were
defined as follows: tubular necrosis: 0, normal tubules; 1, rare single
necrotic tubule; 2, several clusters of necrotic tubules; 3, confluence of
necrotic clusters; tubular atrophy: 0, normal tubules; 1, rare single
atrophic tubule; 2, several clusters of atrophic tubules; 3, confluence of
atrophic tubular clusters; lymphocytic infiltrate: 0, absent; 1, few scattered
cells; 2, group of lymphocytes; 3, widespread infiltrate; interstitial fibrosis:
0, absent; 1, minimal fibrosis; 2, moderate fibrosis; 3, severe fibrosis.
Tubular basement membrane staining (2mm sections) was
performed with the Artisan Jones basement membrane stain kit
(DakoCytomation, Glostrup, Denmark).
For collagen-specific labeling (4mm sections), 0.1% Sirius red
F3B in saturated picric acid (both from Sigma-Aldrich, Bornem,
Belgium) was used.
Electron microscopy was performed as previously reported.43
Briefly, kidney cortex samples were fixed (4% glutaraldehyde), post-
fixed (2% osmium tetroxide), dehydrated, and embedded in Epon.
The semithin sections were stained with toluidine blue. Ultrathin
sections counterstained with uranyl acetate and lead citrate were
examined with a Zeiss EM109 electron microscope (Carl Zeiss).
Biochemical evaluation of renal function
Plasma and urinary Cr excretion levels were determined as
previously described.8
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Figure 7 | Kidney a-SMA tissue expression and time course of a-SMA semiquantitative evaluation. Sirius red and collagen type I
and III staining in representative control and AA rats. (a) Absence of a-SMA expression in controls. (b and c) Progressive interstitial
accumulation of a-SMA-positive cells (arrow) in AA rats (gray boxes) as compared to controls (horizontal bars). Data are median values
together with the interquartile ranges and the min–max values; *Po0.05, **Po0.01 vs day 1. (d) As compared to controls, (e, day 10)
remodeling of the basement membrane (arrow) of necrotic tubules (star) and (f, day 35) marked thickening of the basement membrane
(arrow) of degenerative tubules (star) in AA rats. (g and j) Absence of collagen type I and III immunostaining in control kidneys. In AA rats,
progressive apposition of collagen type I (h, day 10 and i, day 35) and collagen type III (k, day 10 and l, day 35) in the external parts of the
medullary rays. (a, b, and g–l) Sections were counterstained with Mayer’s hematoxylin. (d–f) Sirius red staining. Original magnification:  400.
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Determination of DPPIV urinary activity
Urinary activity of DPPIV was monitored by spectrofluorometric
method. Two diluted urine samples were incubated at 37 1C with the
synthetic substrate for DPPIV, leucine-7-amido-4-methyl-coumarin
(Bachem, Dubendorf, Switzerland). The fluorescence of free
AMC was measured at excitation and emission wavelength of 367
and 440 nm, respectively. Results were calculated as mean of
fluorescence from two dilutions and expressed as mmol of AMC
product per g Cr.
Immunoassay of MCP-1
Urinary excretion of MCP-1 was measured by Rat MCP-1 immunoassay
kit, according to the manufacturer’s protocol (BioSource International
Inc., Nivelles, Belgium) and expressed in ng per g Cr.
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Figure 8 | Time courses of renal cortex antioxidant enzyme activity in control and AA rats. (a–c) In control (white bars) and AA rats
(gray bars), renal cortex activity of (a) Mn-SOD, (b) glutathione peroxidase (GPx), (c) Cu/Zn-SOD, and (d) catalase was assessed. Data are median
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Figure 9 | Representative photomicrographs of iNOS, cytochrome c, and cleaved caspase-3 staining in renal medullary rays from control
and AA rats. (a) Pattern of iNOS expression in controls. (b, day 4 and c, day 35) Progressive disappearance of iNOS staining (arrow) from PTEC
in AA rats. (d) Granular cytoplasmic expression of cytochrome c in controls. (e, day 4 and f, day 35) Diffuse cytoplasmic cytochrome c staining in a
non-necrotic PTEC (arrow), corresponding to its release from the mitochondrial membrane into the cytoplasm. (g, day 3) Absence of caspase-3
immunostaining in a control rat. (h, day 10 and i, day 35) Cytoplasmic expression of active caspase-3 in tubular cells (arrows) from AA rats, reflecting
an induction of tubular cell apoptosis. Sections were counterstained with Mayer’s hematoxylin. Original magnifications: (a–c)  200; (d–i)  1000.
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Immunohistochemistry
Immunohistochemistry with monoclonal antibodies (Table 2) was
performed as detailed previously.44 Visualization of polyclonal
antibodies (Table 2) was obtained using anti-rabbit secondary
antibody (DakoCytomation). Control for labeling was carried out
with normal serum or antibody diluent (DakoCytomation) instead
of primary antibody and showed no staining.
Double immunostaining
First, primary antibody immunoperoxidase staining was performed with
diaminobenzidine/substrate (Vector Laboratory, Burlingame, CA, USA).
After a microwave elution step, a second complete immunoperoxidase
staining was performed with diaminobenzidine/nickel substrate or
NovaRed (Vector Laboratory) as a secondary indication system.
Computer-assisted microscopy of tissue area measurement
Quantification of kidney tissue area was adapted from D’Haene
et al.45 Per animal, 400 cortical and OSOM fields (17.6 mm2) on
hematoxylin-stained sections were automatically scanned with a
 20 magnification lens of an optical microscope (Olympus,
Optical Co. Ltd, Aartselaar, Belgium) and visualized by video
camera (Sony Corporation, Tokyo, Japan). The image analysis
software measured (mm2) analyzed tissue area.
Quantification of immunostainings
All quantifying methods were validated by estimation of reprodu-
cibility in both rat groups and showed a high rate of concordance
(495%) for intra-assay and inter-assay determinations. Quantifica-
tions were performed by one investigator (AP) blind to the group
origin of the rats (AA vs control groups). Fields containing more
than two glomeruli or large vessels were excluded.
The patterns of Ki-67 and PCNA expression were defined as
nuclear staining. Cortical and OSOM areas were analyzed ( 40
magnification lens). The PCNA or Ki-67 positively stained PTECs
were counted in 30 fields and expressed as an average of PCNAþ or
Ki-67þ cells per field.
The NEP expression patterns defined as PTEC apical staining and
S100A4 cytoplasmic staining were quantified as previously detailed.9
The intensity of N-cadherin basolateral membrane staining in
PTECs was scored from 0 to 3 (0, absence; 1, very weak; 2, weak; 3,
high staining).
The PTEC tubular basement membrane denudation studied on
Jones membrane-stained sections and the a-SMA immunostaining
were scored from 0 to 3 (0, absence; 1, very rare; 2, rare; 3, frequent).
For each rat, a complete kidney section was analyzed with a  20
and  40 magnification lenses.
Urinary concentration of NOx
Equal amounts of NADH (0.9 mM), FAD (15 mM), and nitrate
reductase (0.4 U ml1) were incubated with diluted urine samples.
Equal amounts of lactate dehydrogenase (20 U ml1), sodium
pyruvate (100 mM), and Gries reagent were added. Optical density
was measured at 540 nm and expressed in mmol per mmol Cr after
comparison to a standard curve.
Cortex antioxidant enzyme activities
Kidney cortex samples were homogenized (2% w/v in 50 mM
potassium phosphate with 0.1 mM EDTA and 1% Triton X-100).
Catalase activity ( 103 per s per mg protein) was assayed
spectrophotometrically.46 Total SOD and Mn-SOD activities (after
Cu/Zn-SOD inhibition by potassium cyanide) were determined.47
Cu/Zn-SOD activity (U per mg protein) was calculated as a
difference of total SOD and Mn-SOD activity. The glutathione
peroxidase activity (seleniumþ non-selenium-dependent) (U per
mg protein) was assayed as detailed.48
Table 1 | Variables studied during the acute and chronic
phases of AAN
Variables Functional significance
Tubulointerstitial injury score, structural and functional renal parameters
H&E Evaluation of tubular necrosis and interstitial infiltration
GT Evaluation of tubular atrophy and interstitial fibrosis
DPPIV Urinary excretion levels reflect structural integrity of
PTEC
Creatinine Renal function evaluation
Characterization of interstitial inflammation
CD8 Identification of infiltrating cells expressing CD8
antigen
ED1 Identification of monocytes and tissue macrophages
MCP-1 Secreted by renal residents cells, mononuclear cells,
and activated fibroblasts, involved in their recruitment
in the zone of tissue injury
DNA damage repair and cells proliferation
Ki-67 Nuclear protein expressed during all active phases of
the cell cycle
PCNA Cofactor of polymerases involved in DNA synthesis,
recombination, and DNA damage repair processes
PTEC dedifferentiation, tubular basement membrane disintegration
NEP PTEC brush-border enzyme highly expressed by PTECs
from S3 segments
Vimentin Intermediate filament protein of undifferentiated
(mesenchymal) cells, fibroblasts, and endothelial cells
E-cadherin PTEC apical membrane protein, critical to the cells
structure maintenance
N-cadherin Transmembrane protein mediating intercellular
adhesion of PTECs, crucial for maintenance of their
polarity
Jones staining Evaluation of tubular basement membrane integrity
TGF-b Cytokine involved in fibrosis by stimulating fibroblasts
proliferation, EMT process, and collagen deposition
a-SMA Actin of the smooth muscle cells and myofibroblast
cytoskeleton
S100A4 Calcium-binding protein expressed by fibroblasts,
T lymphocytes, and plasma cells
Sirius red Extracellular matrix apposition
Collagen I, III Evaluation of interstitial fibrosis
Oxidative stress, mitochondrial injury, and apoptosis
Mn-SOD Mitochondrial antioxidative enzyme
Cu/Zn-SOD Extracellular antioxidative enzyme
GPx Glutathione peroxidase
Catalase Peroxisomal antioxidative enzyme
TBARS Products of lipid membrane peroxidation
iNOS Inducible nitric oxide synthase exacerbating renal
oxidative damage22
Cytochrome c Marker of structural mitochondrial integrity
Caspase-3 Activated caspase-3 responsible for the induction
of cell apoptosis
AAN, aristolochic acid nephropathy; Cu/Zn-SOD, copper/zinc superoxide dismutase;
DPPIV, dipeptidyl peptidase IV; EMT, epithelial to mesenchymal transition; GT,
Goldner’s trichrome; H&E, hematoxylin and eosin; iNOS, inducible nitric oxide
synthase; MCP-1, monocyte chemoattractant protein-1; Mn-SOD, manganese
superoxide dismutase; NEP, neutral endopeptidase; PCNA, proliferating cell nuclear
antigen; PTEC, proximal tubular epithelial cells; a-SMA, a-smooth muscle actin;
TBARS, thiobarbituric acid reactive substances; TGF-b, transforming growth factor-b.
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Cortex lipid peroxidation
Lipid peroxidation fluorometric assay for measuring TBARS was
adapted from Yagi.49 Briefly, 55 ml of 1% butylated hydroxytoluene
in 95% ethanol was added to 4 ml of 40 mmol per l H2SO4, followed
by 100ml of cortex homogenate (10% w/v in PBS with 13.4 mM
EDTA and 6.5 mM glutathione sulfhydryl), then by 500 ml of
35 mmol per l tungstophosphoric acid and 1 ml of 46 mmol per l
thiobarbituric acid in 6 mol per l acetic acid. Samples were heated
(95 1C, 1 h). The reaction mixture was extracted with n-butanol and
measured at 525 nm for excitation and 547 nm for emission using a
Hitachi F2000 fluorometer, and TBARS concentration was expressed
as pmol per mg protein. Cortical protein (mg) was determined by
bicinchoninic acid method (Pierce, Rockford, IL, USA).
Statistical analysis
The TI injury, N-cadherin, PTEC tubular membrane denudation,
and a-SMA scores were analyzed in both rat groups by comparing
the data from each time point to those of day 1 of the protocol
(Kruskal–Wallis analysis of variance and post hoc Dunn tests). All the
remaining scores obtained from AA and control groups were
compared for each corresponding time point (Mann–Whitney
U-test). Correlations between different variables were determined
using the Spearman rank correlation coefficient. A P-value lower
than 0.05 was considered to be significant.
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